Artivion (AORT) closed at $23.30 on October 23, 2026, down 2.8% from the previous close, on volume of 377,159 shares (30-day average 557,623).
Data as of October 23, 2026.
23-Oct-2026
No headlines found.
PRNewswire (Thu, 22-Oct 4:10 PM ET)
Artivion Reports Second Quarter 2026 Financial Results
PRNewswire (Thu, 6-Aug 4:05 PM ET)
Artivion to Participate in Upcoming Investor Conferences
PRNewswire (Tue, 28-Jul 4:10 PM ET)
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Artivion trades on the NYSE stock market under the symbol AORT.
As of October 23, 2026, AORT stock price declined to $23.30 with 377,159 million shares trading.
AORT has a beta of 0.24, meaning it tends to be less sensitive to market movements. AORT has a correlation of 0.00 to the broad based SPY ETF.
AORT has a market cap of $1.14 billion. This is considered a Small Cap stock.
Last quarter Artivion reported $126 million in Revenue and $.13 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.03.
In the last 3 years, AORT traded as high as $48.25 and as low as $12.16.
The top ETF exchange traded funds that AORT belongs to (by Net Assets): IJR, VTI, IWM, VXF, IJT.
AORT has underperformed the market in the last year with a return of -46.4%, while the SPY ETF gained +14.9%. In the last 3 month period, AORT fell short of the market, returning -7.3%, while SPY returned +1.9%. However, in the most recent 2 weeks AORT has outperformed the stock market by returning +9.9%, while SPY returned -1.8%.
AORT support price is $23.33 and resistance is $24.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AORT shares will trade within this expected range on the day.
